Clinical Features and Treatment of Systemic JIA in Children (CST-SJIA)
Clinical Characterization and Different Therapeutic Modalities in Children With Systemic Juvenile Idiopathic Arthritis
研究概览
详细说明
Systemic juvenile idiopathic arthritis (sJIA) is a chronic inflammatory disease of childhood characterized by systemic manifestations such as recurrent fever, evanescent rash, lymphadenopathy, hepatosplenomegaly, and serositis, with or without arthritis. The disease may have a variable clinical course and can be associated with significant complications, including macrophage activation syndrome (MAS).
This study aims to clinically characterize children with sJIA and describe the different therapeutic modalities used in their management. The study will include children younger than 18 years who fulfill the 2019 PRINTO classification criteria for systemic juvenile idiopathic arthritis.
Clinical and laboratory data will be collected, including demographic characteristics, presenting manifestations, disease activity, inflammatory markers, relevant laboratory investigations, complications, and treatment modalities. Information regarding corticosteroids, conventional disease-modifying antirheumatic drugs, and biologic therapies will be documented according to the treatment received as part of routine clinical care.
Participants will be followed prospectively to assess their clinical course, disease activity, response to treatment, treatment-related outcomes, and occurrence of complications. The study is observational; treatment decisions will not be assigned by the study protocol and will remain according to the treating physician's clinical judgment.
The study will provide a clinical characterization of sJIA in children and describe outcomes associated with the different therapeutic modalities used in routine clinical practice.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Amira Gamal Mohammed, Master's degree
- 电话号码:01015797592
- 邮箱:merogamal005@gmail.com
学习地点
-
-
-
Sohag、埃及
- Sohag university hospital
-
接触:
- Amira Gamal Mohammed
- 电话号码:01015797592
- 邮箱:merogamal005@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Children aged <18 years.
- Children diagnosed with systemic juvenile idiopathic arthritis (sJIA) according to the 2019 PRINTO classification criteria.
- Both newly diagnosed and previously diagnosed children with sJIA attending the study center.
Exclusion Criteria:
- Children with other rheumatic or autoimmune diseases.
- Children with infectious, malignant, or other systemic diseases that may mimic sJIA.
- Patients whose medical records have insufficient data for assessment.
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Disease Activity in Children with Systemic Juvenile Idiopathic Arthritis
大体时间:At baseline and at 1, 3, 6, 9, and 12 months after treatment initiation.
|
Disease activity will be assessed using the Juvenile Arthritis Disease Activity Score-10 (JADAS-10) at baseline and during follow-up after treatment initiation.
|
At baseline and at 1, 3, 6, 9, and 12 months after treatment initiation.
|
合作者和调查者
调查人员
- 首席研究员:Amira Gamal Mohammed, Master、Sohag University
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- Soh-Med-26-6-10MS
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.